The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)for Bronchiolitis Obliterans Syndrome4 locations incl. Palo AltoSponsor: Fred Hutchinson Cancer CenterSex: All·Age: 8+Code: NCT05250037·RecruitingApply to this trial
Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasmsfor Acute Biphenotypic LeukemiaDrug: Venetoclax1 location in SeattleSponsor: University of WashingtonSex: All·Age: 18+Code: NCT04797767·Phase 1, Phase 2·RecruitingApply to this trial
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disordersfor Non-Neoplastic Hematopoietic and Lymphoid Cell Disorder1 location in SeattleSponsor: Fred Hutchinson Cancer CenterSex: All·Age: Up to 50Code: NCT03980769·Phase 2·RecruitingApply to this trial
Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancerfor Castration-Resistant Prostate Carcinoma4 locations incl. BaltimoreSponsor: University of WashingtonSex: Male·Age: 18+Code: NCT04489719·RecruitingApply to this trial
Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosisfor Primary Myelofibrosis1 location in SeattleSponsor: Fred Hutchinson Cancer CenterSex: All·Age: 18 - 70Code: NCT04370301·Phase 2·RecruitingApply to this trial
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignanciesfor Acute Leukemia1 location in SeattleSponsor: Fred Hutchinson Cancer CenterSex: All·Age: 6 Months+·Accepts healthy volunteersCode: NCT04195633·Phase 2·RecruitingApply to this trial
CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemiafor Recurrent Acute Myeloid Leukemia1 location in SeattleSponsor: Fred Hutchinson Cancer CenterSex: All·Age: 18+Code: NCT04375631·Phase 1·RecruitingApply to this trial
Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphomafor Aggressive Non-Hodgkin LymphomaDrug: Polatuzumab Vedotin1 location in SeattleSponsor: University of WashingtonSex: All·Age: 18+Code: NCT04231877·Phase 1·RecruitingApply to this trial
Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Studyfor Prostate Adenocarcinoma2 locations incl. PittsburghSponsor: University of WashingtonSex: Male·Age: 18+Code: NCT04175431·Phase 2·RecruitingApply to this trial
Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Studyfor Chronic Graft Versus Host Disease9 locations incl. GainesvilleSponsor: Fred Hutchinson Cancer CenterSex: All·Age: 18+Code: NCT04431479·RecruitingApply to this trial
Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseasesfor Non-Malignant Neoplasm1 location in SeattleSponsor: Fred Hutchinson Cancer CenterSex: All·Age: 18 - 49Code: NCT04083183·Phase 1, Phase 2·RecruitingApply to this trial
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Studyfor Prostate Carcinoma8 locations incl. DuarteSponsor: University of WashingtonSex: Male·Age: 40+·Accepts healthy volunteersCode: NCT04472338·RecruitingApply to this trial
Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasmsfor Acute Myeloid LeukemiaDrug: Ruxolitinib1 location in SeattleSponsor: University of WashingtonSex: All·Age: 18+Code: NCT04282187·Phase 2·RecruitingApply to this trial
Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)for Acute Leukemia3 locations incl. TampaSponsor: Fred Hutchinson Cancer CenterSex: All·Age: 1 - 60Code: NCT03970096·Phase 2·RecruitingApply to this trial
PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancerfor Metastatic Lung Non-Small Cell Carcinoma1 location in SeattleSponsor: University of WashingtonSex: All·Age: 18+Code: NCT04151940·RecruitingApply to this trial
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplantfor Acute Biphenotypic Leukemia10 locations incl. Los AngelesSponsor: Fred Hutchinson Cancer CenterSex: All·Age: 6 Months - 26·Accepts healthy volunteersCode: NCT03779854·Phase 2·RecruitingApply to this trial
211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndromefor Acute Lymphoblastic Leukemia in Remission1 location in SeattleSponsor: Fred Hutchinson Cancer CenterSex: All·Age: 18 - 75Code: NCT03670966·Phase 1, Phase 2·RecruitingApply to this trial
Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS Studyfor Prostate Carcinoma1 location in SeattleSponsor: Fred Hutchinson Cancer CenterSex: Male·Age: 35 - 89·Accepts healthy volunteersCode: NCT04254133·Enrolling By Invitation
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplantfor Juvenile Myelomonocytic Leukemia1 location in SeattleSponsor: Fred Hutchinson Cancer CenterSex: All·Age: Up to 80Code: NCT03326921·Phase 1·RecruitingApply to this trial
211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemiafor Acute Lymphoblastic Leukemia1 location in SeattleSponsor: Fred Hutchinson Cancer CenterSex: All·Age: 18 - 75Code: NCT03128034·Phase 1, Phase 2·RecruitingApply to this trial
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancerfor Localized Renal Pelvis and Ureter Urothelial Carcinoma1 location in SeattleSponsor: University of WashingtonSex: Male·Age: 18+·Accepts healthy volunteersCode: NCT01050504·RecruitingApply to this trial